Pratt's rat research suggests GLP-1 signaling can blunt reward-driven eating. He says evidence doesn't yet support GLP-1s as a binge eating disorder treatment.
Recap by typeshit. Full story at Psychiatric Times.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Gaetano Santulli's team surveys approved oral options and late-stage pill candidates, arguing they could reach patients who avoid injections.
After 12 months, GLP-1 users shed 14.8% of the weight they had regained versus 8.1% for nonusers. Researchers stress the study was observational and small.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Loading…